Literature DB >> 25158828

Cancer stem cells--important players in tumor therapy resistance.

Selcuk Colak1, Jan P Medema.   

Abstract

Resistance to tumor therapy is an unsolved problem in cancer treatment. A plethora of studies have attempted to explain this phenomenon and many mechanisms of resistance have been suggested over recent decades. The concept of cancer stem cells (CSCs), which describes tumors as hierarchically organized, has added a new level of complexity to therapy failure. CSCs are the root of cancers and resist chemo- and radiotherapy, explaining cancer recurrence even many years after therapy is ended. This review discusses briefly CSCs in cancers, gives an overview of the role of CSCs in therapy resistance, and discusses the potential means of targeting these therapy-resistant tumor cells.
© 2014 FEBS.

Entities:  

Keywords:  cancer; cancer stem cell; chemotherapy; resistance; tumor-initiating cells

Mesh:

Substances:

Year:  2014        PMID: 25158828     DOI: 10.1111/febs.13023

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  97 in total

1.  Cancer stem cells don't waste their time cleaning-low proteasome activity, a marker for cancer stem cell function.

Authors:  Kristiaan J Lenos; Louis Vermeulen
Journal:  Ann Transl Med       Date:  2016-12

Review 2.  Mixed signals from the cell's antennae: primary cilia in cancer.

Authors:  Thibaut Eguether; Michael Hahne
Journal:  EMBO Rep       Date:  2018-10-22       Impact factor: 8.807

Review 3.  New Opportunities and Challenges to Defeat Cancer Stem Cells.

Authors:  Erika K Ramos; Andrew D Hoffmann; Stanton L Gerson; Huiping Liu
Journal:  Trends Cancer       Date:  2017-09-21

4.  STRAP Promotes Stemness of Human Colorectal Cancer via Epigenetic Regulation of the NOTCH Pathway.

Authors:  Lin Jin; Trung Vu; Guandou Yuan; Pran K Datta
Journal:  Cancer Res       Date:  2017-08-21       Impact factor: 12.701

Review 5.  AML chemoresistance: The role of mutant TP53 subclonal expansion and therapy strategy.

Authors:  Bowen Yan; David Claxton; Suming Huang; Yi Qiu
Journal:  Exp Hematol       Date:  2020-06-20       Impact factor: 3.084

6.  Cutaneous metastases of breast cancer during adjuvant chemotherapy correlates with increasing CD44+/CD24- and ALDH-1 expression: a case report and literature review.

Authors:  Jung Sun Lee; Woo Gyeong Kim
Journal:  Stem Cell Investig       Date:  2018-03-27

7.  Wnt signaling regulates the stemness of lung cancer stem cells and its inhibitors exert anticancer effect on lung cancer SPC-A1 cells.

Authors:  Xueyan Zhang; Yuqing Lou; Huimin Wang; Xiaoxuan Zheng; Qianggang Dong; Jiayuan Sun; Baohui Han
Journal:  Med Oncol       Date:  2015-03-03       Impact factor: 3.064

Review 8.  Resistance to anticancer immunity in cancer patients: potential strategies to reverse resistance.

Authors:  B Bonavida; S Chouaib
Journal:  Ann Oncol       Date:  2017-03-01       Impact factor: 32.976

9.  TRAP1 regulates stemness through Wnt/β-catenin pathway in human colorectal carcinoma.

Authors:  Giacomo Lettini; Lorenza Sisinni; Valentina Condelli; Danilo Swann Matassa; Vittorio Simeon; Francesca Maddalena; Marica Gemei; Elvira Lopes; Giulia Vita; Luigi Del Vecchio; Franca Esposito; Matteo Landriscina
Journal:  Cell Death Differ       Date:  2016-09-23       Impact factor: 15.828

10.  MicroRNA-218 inhibits the migration, epithelial-mesenchymal transition and cancer stem cell properties of prostate cancer cells.

Authors:  Bing Guan; Lijun Mu; Linlin Zhang; Ke Wang; Juanhua Tian; Shan Xu; Xinyang Wang; Dalin He; Yuefeng Du
Journal:  Oncol Lett       Date:  2018-06-01       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.